<DOC>
	<DOCNO>NCT01064999</DOCNO>
	<brief_summary>Neoadjuvant chemoradiotherapy ( CRT ) standard therapy local advance rectal cancer . Pathological complete response ( pCR ) important prognostic factor local control survival . A high intensity CRT increase pCR rate , also toxicity , especially diarrhea . Compared traditional RT technique , intensity-modified radiation therapy ( IMRT ) decrease toxicity diarrhea low volume high dose small bowel . Therefore , IMRT technique provide opportunity improve dose intensity neoadjuvant CRT . The investigator hypothesize high treatment dose induces high rate pCR design two-arm trial . trial , low intensity CRT include whole pelvic irradiation 50Gy together Oxaliplatin Capecitabine weekly . While high intensity group , additional concomitant 5Gy primary tumor cycle Xelox prescribed . All patient receive total mesorectal excision ( TME ) 8 week CRT .</brief_summary>
	<brief_title>A Trial High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy Locally Advanced Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Patients rectal adenocarcinoma Clinical stag T3/4 nodepositive disease Age : 1875 year Karnofsky Performance Status &gt; 80 Adequate bone marrow reserve , renal hepatic function Without previous antitumoural chemotherapy No evidence metastatic disease Written inform consent randomization Previous pelvis radiotherapy . Previous antitumoural chemotherapy Clinically significant internal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Neoadjuvant chemotherapy</keyword>
	<keyword>locally advanced rectal cancer</keyword>
	<keyword>intensity-modulated radiation therapy</keyword>
	<keyword>pathological complete response</keyword>
</DOC>